Renovia Raises $42M to Back Digital Treatment for Incontinence

10:09 EDT 21 Aug 2018 | Xconomy

Renovia, a company aiming to turn the smartphone into a tool for treating incontinence, has closed $42.3 million in financing as it proceeds with clinical trials. Boston-based Renovia said Tuesday that the new capital consists of $32.2 million in equity funding and $10 million in venture debt. The equity financing, a Series B round of […]

Original Article: Renovia Raises $42M to Back Digital Treatment for Incontinence


More From BioPortfolio on "Renovia Raises $42M to Back Digital Treatment for Incontinence"

Quick Search


Relevant Topics

Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...